MBX vs NAMS: stock comparison and AI forecast
Mbx Biosciences, Inc. (MBX) and Newamsterdam Pharma Co N.V. (NAMS) compared on price performance, valuation, profitability and the daily AI forecast. · Alpha · vs market
Share
MBX Mbx Biosciences, Inc.
- Market Cap
- $2.33B
- P/E Ratio
- –
- Size
- mid-cap
- AI Forecast
NAMS Newamsterdam Pharma Co N.V.
- Market Cap
- $2.26B
- P/E Ratio
- –
- Size
- mid-cap
- AI Forecast
Which one does the AI model favor?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
Key facts
- MBX and NAMS have similar market capitalizations ($2.33B and $2.26B).
- NAMS carries 0.09 times debt per unit of equity, against 0.06 times for MBX.
- Both companies share the SEC industry classification Pharmaceutical Preparations.
Fundamentals side by side
Trailing twelve months.
Valuation & Market
| Metric | MBX | NAMS |
|---|---|---|
| Market Cap | $2.33B | $2.26B |
| P/B Ratio | 5.70x | 3.58x |
| EPS | $-2.58 | $-1.25 |
| Book Value/Share | $8.50 | $5.28 |
| Revenue/Share | – | $0.19 |
| FCF/Share | $-1.77 | $-1.26 |
Profitability & Margins
| Metric | MBX | NAMS |
|---|---|---|
| ROE | -25.5% | -32.5% |
| ROA | -23.9% | -29.8% |
| ROIC | -28.6% | -37.0% |
| Operating Margin | – | -1052.8% |
| Net Margin | – | -924.0% |
| EBT Margin | – | -918.6% |
Financial Health
| Metric | MBX | NAMS |
|---|---|---|
| Current Ratio | 18.08x | 11.76x |
| D/E Ratio | 0.06x | 0.09x |
| Financial Leverage | 1.06x | 1.09x |
| Working Capital | $404M | $615M |
Cash Flow
| Metric | MBX | NAMS |
|---|---|---|
| Operating Cash Flow | -$83M | -$150M |
| Free Cash Flow | -$85M | -$151M |
| Capital Spending | -$3M | -$400K |
| FCF/Sales | – | -680.4% |
| CapEx/Sales | – | 1.8% |
Operational Efficiency
| Metric | MBX | NAMS |
|---|---|---|
| Asset Turnover | – | 0.03x |
| Fixed Assets Turnover | – | 40.0x |
Income Statement
| Metric | MBX | NAMS |
|---|---|---|
| Total Revenue | – | $22M |
| Operating Income | -$118M | -$233M |
| Net Income | -$104M | -$205M |
| R&D Expense | $88M | $158M |
| SG&A Expense | – | $102M |
Dividend & Shareholder Information
| Metric | MBX | NAMS |
|---|---|---|
| Shares Outstanding | 48M | 120M |
MBX vs NAMS: stock comparison and AI forecast
Which is bigger, MBX or NAMS?
MBX and NAMS have similar market capitalizations ($2.33B and $2.26B).
Which one does Intratio's AI model rank higher, MBX or NAMS?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
More comparisons
This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.